Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Most people with consistently high blood pressure have "essential" hypertension, a physician's term for "no known cause." Over the last 20 years, however, studies have shown that 1 in 10 patients do have an identifiable cause. Such patients overproduce the adrenal steroid hormone aldosterone (primary aldosteronism), which raises blood pressure and promotes sodium retention and potassium excretion. On page 768 of this issue, Choi et al. (1) report two different mutations in the gene encoding the potassium channel KCNJ5 in patients (8 of 22) with an aldosterone-producing adrenal adenoma (APA). A third mutation in the same gene is also identified in a father and two daughters with florid adrenal hyperplasia, a hereditary condition that is treated by removing the adrenals in early childhood. The findings have implications for understanding adrenal physiology and pathology.
Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Victoria 3168, Australia.
E-mail: john.funder{at}princehenrys.org
The editors suggest the following Related Resources on Science sites:
In Science Magazine
REPORTS
Murim Choi, Ute I. Scholl, Peng Yue, Peyman Björklund, Bixiao Zhao, Carol Nelson-Williams, Weizhen Ji, Yoonsang Cho, Aniruddh Patel, Clara J. Men, Elias Lolis, Max V. Wisgerhof, David S. Geller, Shrikant Mane, Per Hellman, Gunnar Westin, Göran Åkerström, Wenhui Wang, Tobias Carling, and Richard P. Lifton (11 February 2011) Science331 (6018), 768.
[DOI: 10.1126/science.1198785] |Abstract »|Full Text »|PDF »|Supporting Online Material »
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (15 February 2011) Sci. Signal.4 (160), ec47.
[DOI: 10.1126/scisignal.4160ec47] |Abstract »
D. Penton, S. Bandulik, F. Schweda, S. Haubs, P. Tauber, M. Reichold, L. D. Cong, A. El Wakil, T. Budde, F. Lesage, et al. (2012)
Endocrinology
153, 4740-4748
|Abstract »|Full Text »|PDF »
Platt versus Pickering: what molecular insight to primary hyperaldosteronism tells us about hypertension.
Microarray, qPCR, and KCNJ5 Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors.
E. A. B. Azizan, B. Y. H. Lam, S. J. Newhouse, J. Zhou, R. E. Kuc, J. Clarke, L. Happerfield, A. Marker, G. J. Hoffman, and M. J. Brown (2012)
J. Clin. Endocrinol. Metab.
97, E819-E829
|Abstract »|Full Text »|PDF »
Expression and Mutations of KCNJ5 mRNA in Japanese Patients with Aldosterone-Producing Adenomas.
R. Taguchi, M. Yamada, Y. Nakajima, T. Satoh, K. Hashimoto, N. Shibusawa, A. Ozawa, S. Okada, N. Rokutanda, D. Takata, et al. (2012)
J. Clin. Endocrinol. Metab.
97, 1311-1319
|Abstract »|Full Text »|PDF »
Somatic Mutations Affecting the Selectivity Filter of KCNJ5 Are Frequent in 2 Large Unselected Collections of Adrenal Aldosteronomas.
E. A. B. Azizan, M. Murthy, M. Stowasser, R. Gordon, B. Kowalski, S. Xu, M. J. Brown, and K. M. O'Shaughnessy (2012)
Hypertension
59, 587-591
|Abstract »|Full Text »|PDF »